Additionally, we observed an increase in the frequency of progenitor exhausted cells in the tumor (low in TIM-3+ or high in TCF1+) that occurred between the second and third treatment of FOLFOX (Figure S6A). This evidence concerns the gene HAVCR2 and neoplasm.